A recent systematic review and meta-analysis revealed that moderate to high doses of cannabidiol were associated with liver enzyme elevation and drug-induced liver injury, meeting the criteria of common adverse drug events.Specifically, Lindsay Lo, MSc, BSc, an MPH student at the University of Toronto’s Dalla Lana School of Public Health, and colleagues reported in the Journal of Internal Medicine that people who used cannabidiol (CBD) were nearly six times more likely to have elevated liver enzymes (OR = 5.85; 95% CI, 3.84-8.92) and nearly five times more likely to develop drug-inducedRead More
- (305) 687-1367
- info@flgastro.org
- Mon - Fri: 9:00am - 5:00pm